Arcadia Biosciences, Inc. Altman Z-Score
RKDA|Modified Z-Score (book value) based on FY2025 data
Arcadia Biosciences, Inc.'s Altman Z-Score of 7.60 places the company in the "safe zone" (above 2.9). Historically, companies in this range have had lower rates of financial distress (FY2025).
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 7.60 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Safe Zone (> 2.9)
Safe zone - low probability of financial distress
The Altman Z-Score predicts bankruptcy risk using 5 financial ratios. Learn more
Components: book value of equity, working capital, retained earnings, EBIT, and revenue-to-assets — all derived from SEC FY2025 10-K filings.
5-Factor Decomposition
| Component | Ratio | Weight | Contribution |
|---|---|---|---|
| Working Capital / Total Assets | 0.656 | 0.717 | 0.471 |
| Retained Earnings / Total Assets | - | 0.847 | - |
| EBIT / Total Assets | -0.557 | 3.107 | -1.731 |
| Book Equity / Total Liabilities | 19.266 | 0.420 | 8.092 |
| Revenue / Total Assets | 0.771 | 0.998 | 0.769 |
| Total Z-Score | 7.60 | ||
As of FY2025 · SEC 10-K · Updated Jun 28, 2026
Z-Score Zones
Safe Zone - Company is in strong financial health with low bankruptcy risk.
Grey Zone - Uncertain financial position. Requires closer monitoring.
Distress Zone - Elevated probability of financial difficulties.